← Back to Medicamen Biotech Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

MEDICAMEQPharmaceuticals

Medicamen Biotech Ltd — Financial Ratios & Key Metrics

₹223.30

-4.88%

P/E Ratio50.99xIndustry: 31.77x

ROE3.39%Return on equity

ROCE5.61%Return on capital

Debt/Equity0.14Low debt

💎

Valuation & Profitability

P/E Ratio

50.99x

Industry Average P/E

31.77x

Dividend Yield

0.25%

Market Cap

₹545.08 (Cr)

Sales Growth 5Y

5.31%

Profit Growth 5Y

-11.81%

EPS Growth 5Y

-12.51%

OPM 5Y Avg

14.92%

📉

Price Returns

1 Month

+6.70%

3 Months

+14.55%

6 Months

-7.43%

1 Year

-9.45%

52W Low

₹234

Current

₹223

52W High

₹544

-4% of 52-week range — Near lows

🔬

Technical Indicators

Oversold

Selling pressure is heavy — potential reversal zone.

SMA 50

₹318

▼ Price below SMA 50 — Bearish

SMA 200

₹359

▼ Long-term downtrend

Volume Signal

343% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Medicamen Biotech Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.